mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
1 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
1 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.002 |
1 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
1 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.0037 |
1 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
1 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |